Company profile: Surmodics
1.1 - Company Overview
Company description
- Provider of surface modification and in vitro diagnostic technologies to the healthcare industry, and developer and commercializer of highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Surmodics
NimbleGen
HQ: United States
Website
- Description: Provider of products and services for the life science research market, offering the SeqCap EZ solution-based capture system that enables exome enrichment in a single test tube, SeqCap EZ libraries covering exome designs, gene panels, and custom content, and SeqCap EZ reagents to maximize workflow.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NimbleGen company profile →
bit.bio
HQ: United Kingdom
Website
- Description: Provider of proprietary cell programming technology and human iPSC-derived cell products for research and drug discovery. Bit.bio develops opti-ox to convert iPSCs into mature, functional human cells and offers ioCells for consistent, scalable supply. The company applies computational principles to biology to code cells for health, including collaboration with The Michael J. Fox Foundation on Parkinson’s research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full bit.bio company profile →
Biocoat
HQ: United States
Website
- Description: Provider of custom-engineered biomaterial coatings for medical devices, specializing in lubricious hydrophilic coatings that deliver lubricity, durability, and low particulate counts. Services include contract coating, custom polymer synthesis, and reagent fulfillment, with specialized hydrophilic solutions for neurovascular and cardiovascular devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biocoat company profile →
Biotix
HQ: United States
Website
- Description: Provider of laboratory consumables and liquid handling solutions, including pipette tips (xTIP4, uTIP, aTIP), the Ergonomix manual pipetting system with light ejection, assay and deep well plates made from medical-grade virgin polypropylene, reagent reservoirs certified free of DNase/RNase/endotoxins, OEM custom consumables design and manufacturing, and Defender face shields for splash protection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotix company profile →
Distributed Bio
HQ: United States
Website
- Description: Provider of computational tools, antibody libraries, and an end-to-end antibody discovery and optimization platform for therapeutic programs, integrating target discovery through clinical development to address challenging targets including GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Distributed Bio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Surmodics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Surmodics
2.2 - Growth funds investing in similar companies to Surmodics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Surmodics
4.2 - Public trading comparable groups for Surmodics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →